| Term 
 
        | Alternate Name/Classification/Onset/Peak/Duration   Lispro |  | Definition 
 
        | Alternate Name: Humalog   Classification: Rapid-acting   Onset: Less than 15 min   Peak:1-1.5h   Duration: 6-8h     |  | 
        |  | 
        
        | Term 
 
        | Alternate Name/Classification/Onset/Peak/Duration   Regular insulin |  | Definition 
 
        | drug of choice in emergent situation Alternate Name: Humulin R Classification: Short-acting Onset:  0.5-1h Peak: 2-3h  Duration: 5-7h only insulin that can be given IV |  | 
        |  | 
        
        | Term 
 
        |     Alternate Name/Classification/Onset/Peak/Duration   NPH insulin |  | Definition 
 
        | Alternate Name: Humulin N   Classification: intermediate-acting   Onset:1-1.5h   Peak: 8-12h   Duration: 18-24h |  | 
        |  | 
        
        | Term 
 
        |   Alternate Name/Classification/Onset/Peak/Duration   Insulin glargine |  | Definition 
 
        | Alternate Name: Lantus   Classification: long-acting   Onset: 1h   Peak: none   Duration: 24h must not be mixed |  | 
        |  | 
        
        | Term 
 
        |   Alternate Name/Classification/Onset/Peak/Duration    Insulin aspart |  | Definition 
 
        |     Alternate Name: Novolog   Classification: rapid-acting   Onset: less than 15 min   Peak: 0.5-1h   Duration: 3-4h |  | 
        |  | 
        
        | Term 
 
        |     Alternate Name/Classification/Onset/Peak/Duration   Insulin glulisine |  | Definition 
 
        | Alternate Name: Apidra   Classification: rapid-acting   Onset: 5-10min   Peak: 1h   Duration: 4h |  | 
        |  | 
        
        | Term 
 
        |     Alternate Name/Classification/Onset/Peak/Duration   Regular insulin |  | Definition 
 
        |     Alternate Name: Novolin R   Classification: short-acting   Onset: 0.5-1h   Peak: 2-3h   Duration: 5-7h |  | 
        |  | 
        
        | Term 
 
        |     Alternate Name/Classification/Onset/Peak/Duration   Insulin detemir |  | Definition 
 
        |     Alternate Name: Levemir   Classification: long-acting (ATI says intermediate)   Onset: 1-2h   Peak: 4-12h   Duration: 6-23h |  | 
        |  | 
        
        | Term 
 
        | Classification/Action   Metformin (Glucophage) |  | Definition 
 
        | Biguanide   Increases binding of insulin to receptors |  | 
        |  | 
        
        | Term 
 
        | Classification/Action   Acarbose (Precose) |  | Definition 
 
        | Alpha-glucoside inhibitor   Inhibits absorption of sugars from GI tract |  | 
        |  | 
        
        | Term 
 
        | Classification/Action   Piogliazone (Actos) |  | Definition 
 
        | Thiazolidinediones   affects insulin receptors by enhancing insulin sensitivity of cells |  | 
        |  | 
        
        | Term 
 
        | Classification/Action   Rosiglitazone (Avandia) |  | Definition 
 
        | Thiazolidinediones    affect insulin receptors by enhancing insulin sensitivity of cells |  | 
        |  | 
        
        | Term 
 
        | Classification/Action   Repaglinide (Prandin) |  | Definition 
 
        | Meglitinides   stimulate release of insulin from pancreatic Islets |  | 
        |  | 
        
        | Term 
 
        | Classification/Action   Neteglinide (Starlix) |  | Definition 
 
        | Meglitinides   simulate release of insulin from pancreatic islets |  | 
        |  |